The potential of retinoids for combination therapy of lung cancer: Updates and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The potential of retinoids for combination therapy of lung cancer: Updates and future directions

Published:2019-09 Issue: Volume:147 Page:104331
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Tripathi Surya Kant,Pandey Kamal,Panda Munmun,Spinella Michael J.,Rengasamy Kannan RR,Biswal Bijesh K

Funder

Department of Science and Technology, Science and Engineering Research Board (DST, SERB)

Department of Science and Technology, Odisha, India

National Institutes of Health

Alex’s Lemonade Stand Foundation to MJS

Konkuk University, Seoul, South Korea

Publisher

Elsevier BV

Subject

Pharmacology

Reference126 articles.

1. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J. Clin.,2016

2. Stem cells, cancer, and cancer stem cells;Reya;Nature,2001

3. Combination treatment with all-trans retinoic acid prevents cisplatin-induced enrichment of CD133+ tumor-initiating cells and reveals heterogeneity of cancer stem cell compartment in lung cancer;Moro;J. Thorac. Oncol.,2015

4. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors;Schug;Cell,2007

5. EMBO Retinoids 2011: mechanisms, biology and pathology of signaling by retinoic acid and retinoic acid receptors;McKenna;Nucl. Recept. Signal.,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapy;Drug Delivery and Translational Research;2024-07-22

2. β-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1α-mediated angiogenesis;Cancer Letters;2024-07

3. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways;Computers in Biology and Medicine;2024-05

4. Fat-soluble Vitamins and Lung Cancer: Where We Are?;Recent Patents on Anti-Cancer Drug Discovery;2024-04-03

5. Current advances of anticancer drugs based on solubilization technology;Nanotechnology Reviews;2024-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3